Int J Stem Cells.  2023 May;16(2):135-144. 10.15283/ijsc22106.

The Suppression Effects of Fat Mass and Obesity Associated Gene on the Hair Follicle-Derived Neural Crest Stem Cells Differentiating into Melanocyte by N6-Methyladenosine Modifying Microphthalmia-Associated Transcription Factor

• Shang Z
• Feng H
• Xia L

• KMID: 2542827
• DOI: http://doi.org/10.15283/ijsc22106

Abstract

Background and Objectives
Melanocyte (MC), derived from neural crest stem cell (NCSC), are involved in the pro-duction of melanin. The mechanism by which NCSC differentiates to MC remains unclear. N6-methyladenosine (m6A) modification was applied to discuss the potential mechanism.
Methods and Results
NCSCs were isolated from hair follicles of rats, and were obtained for differentiation. Cell via-bility, tyrosinase secretion and activity, and transcription factors were combined to evaluated the MC differentiation. RT-qPCR was applied to determine mRNA levels, and western blot were used for protein expression detection. Total m6A level was measured using methylated RNA immunoprecipitation (MeRIP) assay, and RNA immunoprecipitation was used to access the protein binding relationship. In current work, NCSCs were successfully differentiated into MCs. Fat mass and obesity associated gene (FTO) was aberrant downregulated in MCs, and elevated FTO suppressed the differentiation progress of NCSCs into MCs. Furthermore, microphthalmia-associated transcription factor (Mitf), a key gene involved in MC synthesis, was enriched by FTO in a m6A modification manner and degraded by FTO. Meanwhile, the suppression functions of FTO in the differentiation of NCSCs into MCs were reversed by elevated Mitf.
Conclusions
In short, FTO suppressed the differentiating ability of hair follicle-derived NCSCs into MCs by m6A modifying Mitf.

Keyword

Neural crest stem cell; Melanocyte; Differentiation; N6-methyladenosine; FTO; Mitf

Figure

• 

  Fig. 1 Neural crest origin and pluripotency of differentiation of NCSCs. (A) NCSCs in the suspended state. (B) NCSCs in the adherent state. (C) Gene expression profiles of NCSCs. Differentiated cells produce an immune response to (D) β-Tubulin III, (E) SMA and (F) tyrosinase.

• 

  Fig. 2 (A) Tyrosinase-stained cells were prominently increased and (B) the overall cell viability was markedly improved with the MC differentiation. **p<0.01.

• 

  Fig. 3 Identification of MCs differentiated from NCSCs. (A) Tyrosinase activity of MCs derived from NCSCs. (B) Protein levels of tyrosinase and Mitf determined by western blot. (C) mRNA levels of key genes in the formation MCs. (D) A series of recep-tors of melanogenic stimulants on MCs and transcription factors were accessed by RT-qPCR. *p<0.05, **p<0.01.

• 

  Fig. 4 mRNA of seven m6A-associated genes were accessed by RT-qPCR from primary NCSCs and differentiated MCs.

• 

  Fig. 5 FTO participates in the differentiation NCSCs into MCs. (A) mRNA level and (B) Protein expression of FTO in NCSCs with elevated FTO. (C) cell viability of MCs derived from NCSCs with elevated FTO and (D) Tyrosinase activity. (E) Protein levels of tyrosinase and Mitf determined by western blot. (F) mRNA levels of key genes in the formation MCs. (G) A series of receptors of melanogenic stimulants on MCs and transcription factors were accessed by RT-qPCR. *p<0.05, **p<0.01, #p<0.05, ##p<0.01. FTO: fat mass and obesity-associated protein, NCSCs: neural crest stem cells, MCs: mela-nocytes.

• 

  Fig. 6 FTO can modify Mitf by m6A methylation to weaken the stability of Mitf. (A) Total m6A levels of melanogenic factors in MCs with elevated FTO. (B) Mitf enriched by FTO was accessed by RIP experiment method. (C, D) SRAMP was applied to predict the potential theoretical binding sites of Mitf for m6A modi-fication. (E) Luciferase activity of MCs tansfected with overexpression of FTO in both wild-type and mutant-type groups. (F) RT-qPCR assay was conducted to determine the expression of Mitf precursor and mature mRNA in MCs with elevated FTO. (G) The role of FTO in Mitf mRNA stability was assessed by using actinomycin D and RT-qPCR. **p<0.01.

• 

  Fig. 7 Mitf abolished the potency of FTO in MC formation. (A) mRNA level and (B) Protein expression of Mitf in NCSCs with elevated Mitf. (C) Tyrosinase activity and (D) Cell viability of MCs derived from NCSCs with elevated Mitf. (E) Protein levels of tyrosinase and Mitf determined by western blot. (F) mRNA levels of key genes in the formation MCs. (G) A series of receptors of melanogenic stimulants on MCs and transcription factors were accessed by RT-qPCR. *p<0.05, **p<0.01, compared with lv-nc and control groups. #p<0.05, ##p<0.01, compared with FTO+lv-nc group.

Reference

References

1. Lin JY, Fisher DE. 2007; Melanocyte biology and skin pigmen-tation. Nature. 445:843–850. DOI: 10.1038/nature05660. PMID: 17314970.

2. Li M, Knapp SK, Iden S. 2020; Mechanisms of melanocyte polarity and differentiation: what can we learn from other neuroectoderm-derived lineages? Curr Opin Cell Biol. 67:99–108. DOI: 10.1016/j.ceb.2020.09.001. PMID: 33099084.

3. Nishimura EK. 2011; Melanocyte stem cells: a melanocyte reservoir in hair follicles for hair and skin pigmentation. Pigment Cell Melanoma Res. 24:401–410. DOI: 10.1111/j.1755-148X.2011.00855.x. PMID: 21466661.

4. Mort RL, Jackson IJ, Patton EE. 2015; The melanocyte lineage in development and disease. Development. 142:620–632. Erratum in: Development 2015;142:1387. DOI: 10.1242/dev.106567. PMID: 25670789. PMCID: PMC4325379.

5. Le Douarin NM, Dupin E. 2018; The "beginnings" of the neural crest. Dev Biol. 444 Suppl 1:S3–S13. DOI: 10.1016/j.ydbio.2018.07.019. PMID: 30048640.

6. Goding CR, Arnheiter H. 2019; MITF-the first 25 years. Genes Dev. 33:983–1007. DOI: 10.1101/gad.324657.119. PMID: 31123060. PMCID: PMC6672050.

7. Levy C, Khaled M, Fisher DE. 2006; MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med. 12:406–414. DOI: 10.1016/j.molmed.2006.07.008. PMID: 16899407.

8. Murtas D, Pilloni L, Diana A, Casula L, Tomei S, Piras F, Ferreli C, Maxia C, Perra MT. 2019; Tyrosinase and nestin immunohistochemical expression in melanocytic nevi as a histopathologic pattern to trace melanocyte differentiation and nevogenesis. Histochem Cell Biol. 151:175–185. DOI: 10.1007/s00418-018-1730-5. PMID: 30232588.

9. Wang Y, Lan Y, Yang X, Gu Y, Lu H. 2021; TGFβ2 upregulates tyrosinase activity through opsin-3 in human skin melanocytes in vitro. J Invest Dermatol. 141:2679–2689. DOI: 10.1016/j.jid.2021.01.040. PMID: 34029574.

10. Lee JY, Lee J, Min D, Kim J, Kim HJ, No KT. 2020; Tyrosinase-targeting gallacetophenone inhibits melanogenesis in melanocytes and human skin-equivalents. Int J Mol Sci. 21:3144. DOI: 10.3390/ijms21093144. PMID: 32365630. PMCID: PMC7246559. PMID: 39332c0683e5445cbed81376448fe847.

11. Ma S, Chen C, Ji X, Liu J, Zhou Q, Wang G, Yuan W, Kan Q, Sun Z. 2019; The interplay between m6A RNA methylation and noncoding RNA in cancer. J Hematol Oncol. 12:121. DOI: 10.1186/s13045-019-0805-7. PMID: 31757221. PMCID: PMC6874823. PMID: 911a2317a4414c90baf1d56223fab361.

12. Weng H, Huang H, Wu H, Qin X, Zhao BS, Dong L, Shi H, Skibbe J, Shen C, Hu C, Sheng Y, Wang Y, Wunderlich M, Zhang B, Dore LC, Su R, Deng X, Ferchen K, Li C, Sun M, Lu Z, Jiang X, Marcucci G, Mulloy JC, Yang J, Qian Z, Wei M, He C, Chen J. 2018; METTL14 inhibits hematopoietic stem/progenitor differentiation and promotes leukemogenesis via mRNA m6A modification. Cell Stem Cell. 22:191–205.e9. DOI: 10.1016/j.stem.2017.11.016. PMID: 29290617. PMCID: PMC5860916.

13. Wen J, Lv R, Ma H, Shen H, He C, Wang J, Jiao F, Liu H, Yang P, Tan L, Lan F, Shi YG, He C, Shi Y, Diao J. 2018; Zc3h13 regulates nuclear RNA m6A methylation and mouse embryonic stem cell self-renewal. Mol Cell. 69:1028–1038.e6. DOI: 10.1016/j.molcel.2018.02.015. PMID: 29547716. PMCID: PMC5858226.

14. Lin J, Zhu Q, Huang J, Cai R, Kuang Y. 2020; Hypoxia promotes vascular smooth muscle cell (VSMC) differentiation of adipose-derived stem cell (ADSC) by regulating Mettl3 and paracrine factors. Stem Cells Int. 2020:2830565. DOI: 10.1155/2020/2830565. PMID: 32148516. PMCID: PMC7053496. PMID: fb747c2361ac43fbac2aff14024d0151.

15. Vasyliev RG, Gubar OS, Gordiienko IM, Litvinova LS, Rodnichenko AE, Shupletsova VV, Zlatska AV, Yurova KA, Todosenko NM, Khadzhynova VE, Shulha MV, Novikova SN, Zubov DO. 2019; Comparative analysis of biological properties of large-scale expanded adult neural crest-derived stem cells isolated from human hair follicle and skin dermis. Stem Cells Int. 2019:9640790. DOI: 10.1155/2019/9640790. PMID: 30915126. PMCID: PMC6399535. PMID: 53b2e09df6264e01a1ba2614430965a4.

16. Ni Y, Zhang K, Liu X, Yang T, Wang B, Fu L, A L, Zhou Y. 2014; miR-21 promotes the differentiation of hair follicle-deri-ved neural crest stem cells into Schwann cells. Neural Regen Res. 9:828–836. DOI: 10.4103/1673-5374.131599. PMID: 25206896. PMCID: PMC4146246.

17. Dong D, Jiang M, Xu X, Guan M, Wu J, Chen Q, Xiang L. 2012; The effects of NB-UVB on the hair follicle-derived neural crest stem cells differentiating into melanocyte lineage in vitro. J Dermatol Sci. 66:20–28. DOI: 10.1016/j.jdermsci.2012.01.012. PMID: 22391242.

18. Krebs AM, Mitschke J, Lasierra Losada M, Schmalhofer O, Boerries M, Busch H, Boettcher M, Mougiakakos D, Reichardt W, Bronsert P, Brunton VG, Pilarsky C, Winkler TH, Brabletz S, Stemmler MP, Brabletz T. 2017; The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat Cell Biol. 19:518–529. DOI: 10.1038/ncb3513. PMID: 28414315.

19. Ohguchi K, Banno Y, Nakagawa Y, Akao Y, Nozawa Y. 2005; Negative regulation of melanogenesis by phospholipase D1 through mTOR/p70 S6 kinase 1 signaling in mouse B16 melanoma cells. J Cell Physiol. 205:444–451. DOI: 10.1002/jcp.20421. PMID: 15895362.

20. Jin D, Guo J, Wu Y, Du J, Yang L, Wang X, Di W, Hu B, An J, Kong L, Pan L, Su G. 2019; m⁶A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis. J Hematol Oncol. 12:135. Erratum in: J Hematol Oncol 2020;13:106. DOI: 10.1186/s13045-020-00942-x. PMID: 32746876. PMCID: PMC7397643. PMID: e0b20dfa351a4378a85213860c179d3a.

21. Dong G, Yu J, Shan G, Su L, Yu N, Yang S. 2021; N6-methylade-nosine methyltransferase METTL3 promotes angiogenesis and atherosclerosis by upregulating the JAK2/STAT3 pathway via m6A reader IGF2BP1. Front Cell Dev Biol. 9:731810. DOI: 10.3389/fcell.2021.731810. PMID: 34950654. PMCID: PMC8689138. PMID: f13ec458e5234c8ca7886ba0578757ae.

22. Zhou S, Zeng H, Huang J, Lei L, Tong X, Li S, Zhou Y, Guo H, Khan M, Luo L, Xiao R, Chen J, Zeng Q. 2021; Epige-netic regulation of melanogenesis. Ageing Res Rev. 69:101349. DOI: 10.1016/j.arr.2021.101349. PMID: 33984527.

23. Schneider MR, Schmidt-Ullrich R, Paus R. 2009; The hair follicle as a dynamic miniorgan. Curr Biol. 19:R132–R142. DOI: 10.1016/j.cub.2008.12.005. PMID: 19211055.

24. Lee J, Bӧscke R, Tang PC, Hartman BH, Heller S, Koehler KR. 2018; Hair follicle development in mouse pluripotent stem cell-derived skin organoids. Cell Rep. 22:242–254. DOI: 10.1016/j.celrep.2017.12.007. PMID: 29298425. PMCID: PMC5806130.

25. Narytnyk A, Verdon B, Loughney A, Sweeney M, Clewes O, Taggart MJ, Sieber-Blum M. 2014; Differentiation of human epidermal neural crest stem cells (hEPI-NCSC) into virtually homogenous populations of dopaminergic neurons. Stem Cell Rev Rep. 10:316–326. DOI: 10.1007/s12015-013-9493-9. PMID: 24399192. PMCID: PMC3969515.

26. Wilson R, Ahmmed AA, Poll A, Sakaue M, Laude A, Sieber-Blum M. 2018; Human peptidergic nociceptive sensory neurons generated from human epidermal neural crest stem cells (hEPI-NCSC). PLoS One. 13:e0199996. DOI: 10.1371/journal.pone.0199996. PMID: 29953534. PMCID: PMC6023242. PMID: 3c72237a7e5742788c6c4be259b86c07.

27. Dong D, Chen S, Feng C, Xiong H, Xu X. 2020; NB-UVB induces melanocytic differentiation of human hair follicle neural crest stem cells. Ann Dermatol. 32:289–297. DOI: 10.5021/ad.2020.32.4.289. PMID: 33911756. PMCID: PMC7992648.

28. Li J, Zhu L, Shi Y, Liu J, Lin L, Chen X. 2019; m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation. Am J Transl Res. 11:6084–6092. PMID: 31632576. PMCID: PMC6789218.

29. Tao L, Mu X, Chen H, Jin D, Zhang R, Zhao Y, Fan J, Cao M, Zhou Z. 2021; FTO modifies the m6A level of MALAT and promotes bladder cancer progression. Clin Transl Med. 11:e310. DOI: 10.1002/ctm2.310. PMID: 33634966. PMCID: PMC7851431. PMID: 521809a4df2b45918254a3c2d6dd3810.

30. Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, Yang C, Chen Y. 2021; The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 6:74. DOI: 10.1038/s41392-020-00450-x. PMID: 33611339. PMCID: PMC7897327. PMID: 6713afd9239d44a7ad0a9b5c9cd8e10c.

31. Shen GS, Zhou HB, Zhang H, Chen B, Liu ZP, Yuan Y, Zhou XZ, Xu YJ. 2018; The GDF11-FTO-PPARγ axis controls the shift of osteoporotic MSC fate to adipocyte and inhibits bone formation during osteoporosis. Biochim Biophys Acta Mol Basis Dis. 1864:3644–3654. DOI: 10.1016/j.bbadis.2018.09.015. PMID: 30279140.

32. Li L, Zang L, Zhang F, Chen J, Shen H, Shu L, Liang F, Feng C, Chen D, Tao H, Xu T, Li Z, Kang Y, Wu H, Tang L, Zhang P, Jin P, Shu Q, Li X. 2017; Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis. Hum Mol Genet. 26:2398–2411. DOI: 10.1093/hmg/ddx128. PMID: 28398475. PMCID: PMC6192412.

33. Cao Y, Zhuang Y, Chen J, Xu W, Shou Y, Huang X, Shu Q, Li X. 2020; Dynamic effects of Fto in regulating the proliferation and differentiation of adult neural stem cells of mice. Hum Mol Genet. 29:727–735. DOI: 10.1093/hmg/ddz274. PMID: 31751468.